Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

4-(Trifluoromethyl)nicotinic acid  TFNA

4-(Trifluoromethyl)nicotinic acid TFNA

158063-66-2

DISCOVER
Topotecan HCl

Topotecan HCl

119413-54-6

DISCOVER
TYLOSIN CRS (150 MG)

TYLOSIN CRS (150 MG)

1401-69-0

DISCOVER
T2 Triol

T2 Triol

97373-21-2

DISCOVER
Tylosin tartrate - reference spectrum, Qty : n/a

Tylosin tartrate - reference spectrum, Qty : n/a

NA

DISCOVER
TYROSINE CRS (50 MG)

TYROSINE CRS (50 MG)

60-18-4

DISCOVER
Tilmicosin

Tilmicosin

108050-54-0

DISCOVER
TYROTHRICIN CRS (20 MG)

TYROTHRICIN CRS (20 MG)

1404-88-2

DISCOVER
Thebaine

Thebaine

115-37-7

DISCOVER
5-Tolyltriazole D6

5-Tolyltriazole D6

1246820-65-4

DISCOVER
Epitestosterone-17

Epitestosterone-17

481-30-1

DISCOVER
Telmisartan

Telmisartan

144701-48-4

DISCOVER